Venmax Drugs Closes Trading Window for Q1 FY27 Results

Venmax Drugs and Pharmaceuticals Ltd has announced the closure of its trading window for all insiders, including designated persons and their immediate relatives. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be closed effective July 1, 2026, and will reopen forty-eight hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. The specific date for the board meeting to consider these financial results will be intimated separately.